An unplanned interim analysis of the VWDmin study comparing prophylaxis with recombinant VWF (rVWF) to tranexamic acid for HMB found that rVWF was non-superior in patients with mild or moderate VWD.19 The gene discussed is VWF; the disease is von Willebrand disease (hereditary or acquired).